Image credit- rmg-uk.com
Agilent Technologies Inc. has announced that Jacob Thaysen, currently, senior vice president, Agilent and president, Diagnostics and Genomics Group (DGG), has been named president of Agilent’s Life Sciences and Applied Markets Group (LSAG), replacing Patrick Kaltenbach, who left the company on April 20, 2018.
Sam Raha, currently senior vice president, Agilent Strategy and Corporate Development, will become president of DGG.
Thaysen’s and Raha’s appointments as business presidents are effective immediately, and both will continue to report to president and chief executive officer, Mike McMullen.
Jacob Thaysen is a recognized industry leader in life sciences and diagnostics markets. Since joining Agilent in 2012 as part of the acquisition of Dako, a Denmark based cancer diagnostics company, Thaysen has been an integral part of Agilent’s transition into a life sciences company.
Sam joined Agilent to lead the Strategy and Corporate Development team that would help the company create its first long range strategy and more aggressively seek acquisitions that strategically enhance Agilent’s offerings to customers.
